The scores consist of known PCa risk factors (patient’s age [30] and amount of cfDNA [55]) as well as the newly developed DNA methylation biomarkers RASSF1A, MIR129-2, NRIP3, and SOX8. Here, NRIP3 is linked to posterior cortical atrophy.